$OWCP (OWC Pharmaceutical Research Corp.) is still capable

New Post Public Reply Private Reply Replies (0) Message Board
FELLER
460
$OWCP (OWC Pharmaceutical Research Corp.) is still capable of being a 10 Bagger in the coming month(s).

Yes, the stock that's trading at $1.29 as of March 17th.

(Lots of DD at www.OwnTheFloat.com with links to all claims.)

Why? To date, OWCP has risen on the anticipation of their product development, the addition of their Advisory Board members (Dermatologist, FDA Approval specialist), being included in the first ever Cannabis ETF (submitted to SEC, possibly ready by early May), etc.

Early February they reported mid-way through their latest study/trials about having "very encouraging results", which lead to them extending the size and scope of that study. (This is the time they took on the Dermatologist)

Now, their Investor Presentation includes future creams like "Acne, Basal cell carcinoma, Atopic dermatitis and more"

(Source: http://www.owcpharma.com/wp-content/uploads/2...7-ADV.pdf)

Efficacy Test Results are expected any day (by end of March) and that alone should send $OWCP up ~150% in many folks' opinions.

This Psoriasis cream is ready for launch/shipment in early Quarter 2.

Not long after that is their Sublingual Soluble Tablet -- which will be useful for PTSD, Fibromyalgia, Migraines, and more!

Then, we have the Multiple Myeloma (cancer) research they've been doing for beyond a year... Last we heard, they had 100% stagnant cell death in 60% of lab mice... That's huge.

AXIM is going through their process for a product that may be ready by 2018 or even 2019 and their run up was $0.395 to $19.80 in 2.5 months.

OWCP can absolutely run to $13.00+ when they release their first product... It's going to be a huge year for OWCP.

Many of you may have heard about OWCP and figured you're too late, but I say WHY?! Why do you think you can't make big bucks still? The run to $3.23 was just a month ago after it was revealed they were listed in the Cannabis ETF and obviously considered a legit and promising medical marijuana company. Why on Earth wouldn't the PROOF of a phenomenal product NOT send them to another new 52-week High?
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Bank of America Faces Class Action Over False Reports

Updated Category News Views 60

Wall Street's Latest Drama: BAC's Legal Battle Bank of America, the hulking giant of finance, is neck-deep in a new legal whirlwind. They're slapped with a class action suit alleging securities law violations. Branded under the ticker BAC, Bank of America's actions (or lack thereof) have got shareholders shaking their heads and clenching their wallets. What's Got...

Continue Reading
EWTN Broadcasts Pope Leo XIV's Latin America Visit Live

Updated Category News Views 84

Pope Leo XIV Embarks on Landmark Latin America Tour While Wall Street rumbles its daily tune, I've got my eyes on a different spectacle: Pope Leo XIV making rounds in South America from November 6 to 17. This isn't your typical news peg. This stretches beyond financial chatter into a spectacle of faith and cultural resonance. No price charts to weave here, just the...

Continue Reading
ASUR's October Traffic Sees Mixed Results Across Regions

Updated Category News Views 77

A Patchwork of Gains and Losses Take a look at Grupo Aeroportuario del Sureste, S.A.B. de C.V. (NYSE: ASR), and you’ll see a mixed bag when it comes to October 2026’s passenger traffic. While some regions like Puerto Rico and Colombia took a step forward, others like Mexico and Costa Rica tripped up, resulting in an overall decline of 0.9% compared to last October....

Continue Reading
Ast?'s Strategy: Scaling Brands with Operator Insight

Updated Category News Views 71

Defining the Investor-Entrepreneur Partnership Ah, building a consumer brand is no walk in the park, but what about scaling it? Here's where the rubber really meets the road. Enter Ast? Consumer Partners, a firm that clearly understands that scaling a brand isn't all about throwing cash at it—it’s about precision and the right mix of wisdom, much like a seasoned chef...

Continue Reading
Harrison Street & Aegis Living's Strategic Venture Kick-Off

Updated Category News Views 31

New Alliance in Senior Living: Aegis and Harrison Street Team Up Here's something that caught my eye—two heavy hitters in the senior living sector joining forces for what they're calling a strategic joint venture. Harrison Street, known for its real estate investments with a flair for large-scale projects, has shaken hands with Aegis Living, a name synonymous with...

Continue Reading
F&G Boosts Dividend for Investors in Strong Signal

Updated Category News Views 34

Ring the Bell: Dividend Hike from F&G F&G Annuities & Life (NYSE: FG) just raised its dividend, and every investor worth their salt knows that means something. A 4% bump up to $0.26 per common share might not sound like a fanfare, but in the land of finance, it's an indication that this company thinks it's riding a positive wave. It’s like getting a little bonus in your...

Continue Reading
Koozee Boosts Apparel Design with AI Workflows

Updated Category News Views 108

Revolutionizing Apparel Design with AI If you've ever wondered how tech can make an impact on the fashion world, Koozee's latest update provides an eye-opening look. This isn't about following trends—it's about setting them, and Koozee’s making a bold move with its newest platform enhancements. Introducing Freeform Canvas Koozee has launched the Freeform Canvas, a...

Continue Reading
NPA Champions Safe Transit Act for Safer Commutes

Updated Category News Views 57

Public Safety on the Line: The Safe Transit Act When city dwellers head to work or school, the last thing they want is a dicey subway ride. Yet, escalating incidents on transit lines are painting a grim picture. From folks getting pushed onto the tracks to outright assault, it's getting hairy out there. The NPA Puts Its Weight Behind Safety The National Police Association...

Continue Reading
Multi-Society Panel Boosts Vaccine Guidance Clarity

Updated Category News Views 81

Vaccination Confusion: Could Clarity Finally Be Here? Here's the scoop, folks. In the swirling mess of immunization advice, a coalition of top medical societies has thrown a lifeline to clinicians. If you're drowning in conflicting vaccine guidance, this panel's unified stance might just be your life raft. The Coalition Forces of Immunization We have the Vaccine Guidance...

Continue Reading
AiNET Prevails in Breach of Contract Jury Verdict

Updated Category News Views 44

AiNET's Legal Triumph Shakes Up the IT Sector Well, talk about a courtroom drama. Greenberg Traurig just snagged a big win for AiNET over in Prince George's County, Maryland, and it's a classic reminder that due diligence isn't just a nice-to-have—it's a must. AiNET found itself in the center of a breach of contract brawl with Tech Finance Co., and guess what? The jury...

Continue Reading

Top 5 Most Recently Viewed Articles

Shell plc Announces Significant Share Repurchase Activities

Updated Category News Views 155

Shell plc's Share Repurchase Announcement Shell plc, a prominent player in the energy sector, has recently revealed its intention to repurchase shares as part of its ongoing strategy to enhance shareholder value. This initiative underscores the company's commitment to managing its capital effectively and optimizing returns for its investors. Details of the Share Buyback...

Continue Reading
Lucid Faces Legal Turbulence Amid Allegations

Updated Category News Views 12

Lucid Group Under Siege: Allegations Fly Electric vehicle darling Lucid Group (NASDAQ: LCID) is hitting some serious turbulence, and this time it’s not just a bumpy market ride. With litigation in full swing, shareholders are fuming, wondering how things spiraled so fast from innovation glory to a full-blown legal debacle. The allegation? Lucid kept its investors in the...

Continue Reading
Fiverr International Exceeds Revenue Estimates Despite EPS Miss

Updated Category News Views 113

Fiverr International Earnings Overview Fiverr International (NYSE: FVRR) recently announced its third quarter earnings report, revealing an EPS of $0.55, which fell short of the analyst's expectation of $0.59 by $0.04. However, the company impressed with revenue that outstripped forecasts, coming in at $99.63 million compared to the consensus estimate of $96.35 million....

Continue Reading
Steel Dynamics Ends 2024 with Strong Growth and Metrics

Updated Category News Views 736

Steel Dynamics Reports Fourth Quarter and Annual 2024 Results Steel Dynamics, Inc. (NASDAQ: STLD) has recently released impressive financial figures for the fourth quarter and annual 2024. The company reported net sales of $3.9 billion for the last quarter, with a net income of $207 million, equating to $1.36 per diluted share. These results reflect a decrease from the...

Continue Reading
Indian Rupee Stability Anticipated Amid RBI Interventions

Updated Category News Views 277

Indian Rupee Forecast Amid RBI's Market Interventions The Indian rupee is expected to remain within a tight trading range against the U.S. dollar in the coming year, largely due to the Reserve Bank of India's (RBI) active involvement in the foreign exchange market. This perspective is based on a recent survey of foreign exchange analysts. Reasons for Stability in the...

Continue Reading